Reasons to attend
Do you want to understand the activities and specific requirements for the clinical development of a vaccine? This course gives you the answers to the differences with pharmaceutical trials, identifies the challenges, and lets you understand the biological business. We have updated the programme this year, to include a practical workshop on assessing risk/benefit ratio from the point of view of the regulator and the manufacturer.
- Documents and materials related to this course are included
- Globally recognised certificates awarded after test completion
- This course has been granted PharmaTrain Recognition
Day 1: 08h30 - 17h00
Day 2: 08h30 – 12h00
Webinars: 6 sessions
03 Mar 2022: 09:00 - 12:00
07 Mar 2022: 16:00 - 17:30
09 Mar 2022: 16:00 - 17:30
14 Mar 2022: 16:00 - 17:00
16 Mar 2022: 15:00 - 17:00
17 Mar 2022: 15:00 - 17:00
This course highlights the highly demanding activities and specific requirements of regulatory characteristics – the quality, safety, efficacy, and also clinical trial performance in the development of vaccines. We do have 3 exquisite trainers, all having vast experience in vaccine development.
The first part of the course describes the regulatory aspects of the development and marketing authorization of biological medicinal products. The second part focuses on all practical aspects of the performance of clinical trials with vaccines. Finally, the last part will include a workshop where participants will assess the risk/benefit ratio from the point of view of the regulators and manufacturer.